ATXS logo

Astria Therapeutics (ATXS) Total Liabilities

Annual Total Liabilities

$11.55 M
+$2.13 M+22.65%

31 December 2023

ATXS Total Liabilities Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Total Liabilities

$19.98 M
-$927.00 K-4.43%

30 September 2024

ATXS Quarterly Total Liabilities Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

ATXS Total Liabilities Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+22.6%+113.0%
3 y3 years+70.2%+325.2%
5 y5 years+173.2%+259.4%

ATXS Total Liabilities High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 yearsat high+122.0%-4.4%+325.2%
5 y5 yearsat high+173.2%-92.0%+393.9%
alltimeall time-87.0%+173.2%-92.0%+393.9%

Astria Therapeutics Total Liabilities History

DateAnnualQuarterly
Sept 2024
-
$19.98 M(-4.4%)
June 2024
-
$20.91 M(+88.9%)
Mar 2024
-
$11.07 M(-4.1%)
Dec 2023
$11.55 M(+22.7%)
$11.55 M(+23.1%)
Sept 2023
-
$9.38 M(+41.1%)
June 2023
-
$6.65 M(-3.3%)
Mar 2023
-
$6.88 M(-26.9%)
Dec 2022
$9.42 M(+81.0%)
$9.42 M(+35.6%)
Sept 2022
-
$6.95 M(+18.2%)
June 2022
-
$5.87 M(+18.3%)
Mar 2022
-
$4.97 M(-4.5%)
Dec 2021
$5.20 M(-23.3%)
$5.20 M(+10.7%)
Sept 2021
-
$4.70 M(+16.2%)
June 2021
-
$4.05 M(-98.4%)
Mar 2021
-
$249.88 M(+3581.8%)
Dec 2020
$6.79 M(+12.0%)
$6.79 M(-10.0%)
Sept 2020
-
$7.54 M(+21.1%)
June 2020
-
$6.23 M(+13.9%)
Mar 2020
-
$5.46 M(-9.8%)
Dec 2019
$6.06 M
$6.06 M(+9.0%)
DateAnnualQuarterly
Sept 2019
-
$5.56 M(+7.6%)
June 2019
-
$5.17 M(+11.7%)
Mar 2019
-
$4.63 M(+9.5%)
Dec 2018
$4.23 M(-30.8%)
$4.23 M(+1.1%)
Sept 2018
-
$4.18 M(-17.0%)
June 2018
-
$5.04 M(-6.0%)
Mar 2018
-
$5.36 M(-12.2%)
Dec 2017
$6.11 M(-45.1%)
$6.11 M(-20.3%)
Sept 2017
-
$7.66 M(-17.4%)
June 2017
-
$9.27 M(-2.1%)
Mar 2017
-
$9.47 M(-14.9%)
Dec 2016
$11.12 M(-18.7%)
$11.12 M(-7.9%)
Sept 2016
-
$12.08 M(+2.8%)
June 2016
-
$11.75 M(-6.4%)
Mar 2016
-
$12.54 M(-8.3%)
Dec 2015
$13.68 M(-84.6%)
$13.68 M(-3.1%)
Sept 2015
-
$14.11 M(-5.1%)
June 2015
-
$14.87 M(+12.3%)
Mar 2015
-
$13.24 M(-85.1%)
Dec 2014
$89.02 M(+7.0%)
$89.02 M
Dec 2013
$83.19 M
-

FAQ

  • What is Astria Therapeutics annual total liabilities?
  • What is the all time high annual total liabilities for Astria Therapeutics?
  • What is Astria Therapeutics annual total liabilities year-on-year change?
  • What is Astria Therapeutics quarterly total liabilities?
  • What is the all time high quarterly total liabilities for Astria Therapeutics?
  • What is Astria Therapeutics quarterly total liabilities year-on-year change?

What is Astria Therapeutics annual total liabilities?

The current annual total liabilities of ATXS is $11.55 M

What is the all time high annual total liabilities for Astria Therapeutics?

Astria Therapeutics all-time high annual total liabilities is $89.02 M

What is Astria Therapeutics annual total liabilities year-on-year change?

Over the past year, ATXS annual total liabilities has changed by +$2.13 M (+22.65%)

What is Astria Therapeutics quarterly total liabilities?

The current quarterly total liabilities of ATXS is $19.98 M

What is the all time high quarterly total liabilities for Astria Therapeutics?

Astria Therapeutics all-time high quarterly total liabilities is $249.88 M

What is Astria Therapeutics quarterly total liabilities year-on-year change?

Over the past year, ATXS quarterly total liabilities has changed by +$10.60 M (+113.01%)